SUM185PEHomo sapiens (Human)Cancer cell line

Also known as: 185PE, SUM185, SUM 185, SUM-185, SUM 185PE, SUM-185PE

AI Summary

No AI-generated summary available for this cell line.

Basic Information

Database IDCVCL_5591
SpeciesHomo sapiens (Human)
Tissue SourcePleural effusion[UBERON:UBERON_0000175]

Donor Information

Age CategoryUnknown
SexFemale
Subtype Featuresluminal TNBC

Disease Information

DiseaseBreast ductal carcinoma
LineageBreast
SubtypeInvasive Breast Carcinoma
OncoTree CodeBRCA

DepMap Information

Source TypeAsterand
Source IDACH-001392_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Gln144Ter (c.430C>T)Heterozygous-PubMed=29970484, PubMed=11799138, PubMed=8782485, PubMed=8725545
MutationSimplePIK3CAp.His1047Arg (c.3140A>G)Unspecified-PubMed=25926053, PubMed=20570890

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10,12
D13S317
11
D16S539
11
D18S51
13
D21S11
29
D3S1358
15,17
D5S818
12,13
D7S820
8,9
D8S1179
11,14
FGA
23
Penta D
11
Penta E
13
TH01
9
TPOX
8
vWA
18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Development and implementation of the SUM breast cancer cell line functional genomics knowledge base.

Duchinski K., Couch D., Gray J.W., Kappler C.S.

NPJ Breast Cancer 6:30.1-30.14(2020).

Glycoproteins in claudin-low breast cancer cell lines have a unique expression profile.

Yen T.-Y., Bowen S., Yen R., Piryatinska A., Macher B.A., Timpe L.C.

J. Proteome Res. 16:1391-1400(2017).

Modeling precision treatment of breast cancer.";

Collisson E.A., van 't Veer L.J., Spellman P.T., Gray J.W.

Genome Biol. 14:R110.1-R110.14(2013).

miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs.

Martens J.W.M.

Breast Cancer Res. 15:R33.1-R33.17(2013).

Phenotypic and molecular characterization of MCF10DCIS and SUM breast cancer cell lines.

Barnabas N., Cohen D.

Int. J. Breast Cancer 2013:872743.1-872743.16(2013).

Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer.

Chavez K.J., Garimella S.V., Lipkowitz S.

Breast Dis. 32:35-48(2010).

Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines.

den Bakker M.A., Foekens J.A., Martens J.W.M., Schutte M.

Breast Cancer Res. Treat. 121:53-64(2010).

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.

Johnson M.D., Lippman M.E., Ethier S.P., Gazdar A.F., Gray J.W.

Cancer Cell 10:515-527(2006).

Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines.

Wasielewski M., Elstrodt F., Klijn J.G.M., Berns E.M.J.J., Schutte M.

Breast Cancer Res. Treat. 99:97-101(2006).

BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants.

van den Ouweland A.M.W., Merajver S.D., Ethier S.P., Schutte M.

Cancer Res. 66:41-45(2006).

Evidence that both genetic instability and selection contribute to the accumulation of chromosome alterations in cancer.

Edwards P.A.W., Caldas C.

Carcinogenesis 26:923-930(2005).

A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene.

Edwards P.A.W., Chaffanet M.

Genes Chromosomes Cancer 37:333-345(2003).

Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data.

Gooden G.C., Ethier S.P., Kallioniemi A.H., Kallioniemi O.-P.

Cancer Res. 60:4519-4525(2000).

Molecular cytogenetic analysis of 11 new breast cancer cell lines.";

Kallioniemi O.-P., Ethier S.P.

Br. J. Cancer 81:1328-1334(1999).

Constitutive activation of pp125fak in newly isolated human breast cancer cell lines.

Ignatoski K.M.W., Ethier S.P.

Breast Cancer Res. Treat. 54:173-182(1999).